Animal study review shows potential for krill supplementation in obesity, depression and more

Animal study review shows potential for krill supplementation in obesity, depression and more

Researchers from Aker BioMarine recently authored a paper in Nutrients, which comprehensively reviews all animal studies using krill products and aims to give insight into their mechanism of action. The overview also discusses the potential of krill-specific health benefits in humans. Overall, the review article shows that omega-3 fatty acids provided in the form of phospholipids can benefit various organs and help support overall health.

"The reviewed animal studies show improved outcomes of krill oil supplementation for obesity, depression, myocardial infarction, rheumatoid arthritis, ulcerative colitis and more. In particular, the phosphatidylcholine part of krill oil might offer an advantage to people who have issues such as fatty liver disease and mental disorders," said Lena Burri, director of scientific writing, Aker BioMarine Antarctic AS.

"On the other hand, the krill powder, because of its high protein content, could also be of interest for the elderly due to muscle loss and frailty," Burri added.

Line Johnsen, director regulatory affairs, Aker BioMarine Antarctic AS, explained that the summarized benefits described in the paper are important for planning future clinical studies to substantiate the health benefits of Aker BioMarine's krill products in humans.

"Previously, only omega-3 fatty acids have been in focus, but a new direction could also include studies looking at choline benefits," Ms. Johnsen said.

The May 7 Nutrients article can be found here: www.mdpi.com/2072-6643/7/5/3300

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish